EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark INAGENE PERSONALIZING PRESCRIBING was filed as Word mark on 02/03/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/17/2023.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018832114 |
| Application date | February 3, 2023 |
| Publication date | May 10, 2023 |
| Entry date | August 17, 2023 |
| Expiration date | February 3, 2033 |
Trademark owner
802-2345 Yonge St.
M4P 2E5 Toronto
CA
M4P 2E5 Toronto
CA
Trademark representatives
Löjtnantsgatan 21, 5 tr
11550 Stockholm
SE
goods and services
9
Downloadable audio recordings and video recordings containing information in the field of genetic testing for medical and scientific purposes; downloadable educational materials in the fields of genetic testing for medical and scientific purposes and learning management
16
Printed educational materials in the field of genetic testing for medical and scientific purposes, and leaning management
35
Advertising the goods and services of others; arranging and conducting advertising promotional services for the products and services of others; marketing services, namely, providing marketing consultancy for businesses
41
Provision of online non downloadable audio recordings containing information in the field of genetic testing for medical and scientific research purposes; Provision of online non downloadable video recordings containing information in the field of genetic testing for medical and scientific research purposes; providing educational information and non-downloadable educational materials in the fields of genetic testing for medical and scientific purposes and learning management
42
Research in the fields of genomics and genetics; scientific research in the application of personal genetic information with respect to medical or nutritional treatments, pharmaceuticals and clinical trials; providing genetic-based medical, nutritional and pharmaceutical research information via the internet and via online printed publications; medical research in the fields of pharmacogenomics and pharmacogenetics; providing [temporary] use of on-line non-downloadable dedicated software application(s) related to medical conditions addressed by medical testing services namely, platform as a service featuring computer software and mobile device software applications for accessing information related to pharmaceuticals, genetic testing and genetic screening for medical and scientific research purposes, and information in the field of health; providing personalized information online in the field of genetic testing for scientific purposes; genetic testing and genetic screening for scientific research purposes; providing personalized reports online in the field of genetic testing for scientific research purposes; providing an online learning management system consisting of online non-downloadable software for delivering and management e-learning training courses; providing clinical laboratory testing services, namely, pharmacogenetic tests, personalized medical tests, gene sequencing-based tests and genotyping based on the assessment, development and application of genomic discoveries in the medical, pharmaceutical, informatics and clinical diagnostic industries
44
Medical testing services; online services relating to medical testing services, namely, providing genetic testing information and results for patients and healthcare professionals via an internet website portal; online services relating to medical testing services, namely, providing genetic testing and genetic screening information and results for patients and healthcare professionals via an internet website portal; medical information services, namely, reporting and providing feedback to patients and healthcare professionals on pharmacogenetic testing service results and relevance to medical and nutritional treatments and for understanding individual responses to medication; medical information services, namely, analyzing pharmacogenetic testing service results and relevance to medical and nutritional treatments, namely, the interaction between personal genetic information and pharmaceuticals; medical information services, namely, preparation of reports on pharmacogenetic testing service results and relevance to medical and nutritional treatments, namely, analyzing individual pharmacogenetics and the interaction between personal genetic information and pharmaceuticals; providing personalized information online in the field of genetic testing for medical purposes; providing personalized reports online in the field of genetic testing for medical purposes
ID: 11018832114